India to United States: Guaifenesin Export Trade Route

The India to United States Guaifenesin corridor is one of India's established pharmaceutical export routes, with 409 shipments documented worth a combined $14.7M USD. The route is dominated by GRANULES INDIA LIMITED, which alone accounts for roughly 54% of all export value, reflecting the consolidated nature of India's guaifenesin manufacturing sector.

Across 23 active suppliers, the average shipment value stands at $36.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with guaifenesin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 16.6%, placing it at rank #8 among India's top guaifenesin export destinations globally.

On the import side, key buyers of Indian guaifenesin in United States include GRANULES CONSUMER HEALTH, SPIRIT PHARMACEUTICALS LLC, PRODOSE INC. and 50 others. GRANULES CONSUMER HEALTH is the single largest importer with 105 shipments valued at $5.4M USD.

India's guaifenesin exports to United States are driven primarily by a handful of large-scale manufacturers. GRANULES INDIA LIMITED with 154 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 23 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GRANULES INDIA LIMITED, ELYSIUM PHARMACEUTICALS LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together account for 79% of total trade value on this route. The average shipment value of $36.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as guaifenesin extended release tablets 1200mg-14's and acetaminophen guaifenesin dextromethorphen hydrobromide and phenylephrine hcl capsules-913 (annexure-a) as per invoicenos, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, GRANULES CONSUMER HEALTH is the largest importer with 105 shipments worth $5.4M USD — representing 37% of all guaifenesin imports from India on this route. A total of 53 buyers are active on this corridor.